Skip to content

Opening book details…

About this Medicine article

Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg−1 in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004–2008) by E. J. NEUFELD; C. M. KESSLER; J. C. GILL; C. T. WILKE; D. L. COOPER; ON BEHALF OF THE HTRS INVESTIGATORS is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
E. J. NEUFELD; C. M. KESSLER; J. C. GILL; C. T. WILKE; D. L. COOPER; ON BEHALF OF THE HTRS INVESTIGATORS
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley (ISSN 1351-8216)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by E. J. NEUFELD; C. M. KESSLER; J. C. GILL; C. T. WILKE; D. L. COOPER; ON BEHALF OF THE HTRS INVESTIGATORS

Browse all works by E. J. NEUFELD; C. M. KESSLER; J. C. GILL; C. T. WILKE; D. L. COOPER; ON BEHALF OF THE HTRS INVESTIGATORS